Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing metformin use in polycystic ovary syndrome
2023-509259-15-01Phase 4Authorised
- Sponsor
- Helsinki University Hospital
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of metformin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Helsinki University Hospital. Primary endpoints: Anthropometrics (weight), Androgenicity (hirsutism and testosterone) and 3 more. Planned start Feb 2025; status: authorised.
02
Drugs
metformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on 2023-509259-15-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-509259-15-01.